Randomized Controlled Trial on mHealth Intervention for Blood Pressure Control (TelTex4BP)

Location: Tertiary Hospital, Kathmandu, Nepal
Timeline: April 2025 – Ongoing
Partner: Harvard University (under the Lown Scholar Program)


1. Objectives of the Project

Main Objective:
To evaluate the effectiveness and adoption of a structured mobile health (mHealth) intervention—comprising text messages and telephone calls—in improving blood pressure control among adults with hypertension in Nepal.

Specific Objectives:

  • Assess the impact of the structured mHealth intervention on blood pressure control among hypertensive adults.
  • Explore patient engagement and adherence to the mHealth intervention.
  • Identify barriers and facilitators influencing the adoption of digital health tools in hypertension management.
  • Generate evidence to inform scalable digital health solutions for non-communicable disease (NCD) management in low-resource settings.

2. Project Area

The study is being conducted at a tertiary-level hospital in Kathmandu, in collaboration with the Sahid Gangalal National Heart Center.

  • Focus Group: Adults diagnosed with hypertension.
  • Intervention: Structured mHealth approach using automated text messages and periodic telephone calls.
  • Study Design: Randomized Controlled Trial (RCT).
  • Project Duration: 2 years, with a one-year follow-up period post-enrolment.

3. Snapshot of Project Activities

S.N.Activities
3.1Contract established between Apara Innovations and Harvard University under the Lown Scholar Program
3.2Development of study protocol, ethical approval, and preparatory groundwork
3.3Formative research conducted to identify barriers to effective hypertension management
3.4Design and customization of the structured mHealth intervention (Text & Call Modules)
3.5Recruitment and enrolment of participants (scheduled from September 2025)
3.6Randomization and baseline data collection
3.7Implementation of mHealth intervention and continuous participant follow-up
3.8Midline and endline data collection to evaluate intervention effectiveness
3.9Analysis of intervention outcomes and adoption levels
3.10Dissemination of findings through academic publications and stakeholder presentations

4. Benefits of the Project

Health Benefits

  • Promotes improved blood pressure control among hypertensive adults.
  • Enhances patient adherence to medication and healthy lifestyle practices.
  • Contributes to the prevention of cardiovascular complications through better self-management.

Research and Policy Benefits

  • Provides high-quality evidence on the effectiveness of digital health interventions in hypertension management.
  • Supports policy formulation for integrating mHealth solutions into national NCD programs.
  • Strengthens Nepal’s capacity for conducting large-scale randomized controlled trials.

Technological and Social Benefits

  • Demonstrates the feasibility of using mobile technology to improve chronic disease management.
  • Encourages digital health literacy among patients and healthcare workers.
  • Builds sustainable models for technology-enabled community health interventions.

5. Collaborators

  • Harvard University (Lown Scholar Program)
  • Sahid Gangalal National Heart Center
  • Apara Innovations

6. Project Leads

Principal Investigator:
Dr. Buna Bhandari

  • Oversees the scientific design and implementation of the randomized controlled trial.

Project Lead:
Ms. Rabina Dhakal

  • Leads the project operations and coordinates research activities in close collaboration with Sahid Gangalal National Heart Center.